DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
|
|
- Hugo Sparks
- 5 years ago
- Views:
Transcription
1 DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated income for For audit purposes, please keep conflict of interest/financial records for three years after the conclusion of the award. How to Use This Form: 1) Save the document on your drive. 2) Enter the Year (e.g. 2014/2015), your Name, Title and Address in the appropriate fields. 3) Make sure you save your version on your drive. 4) Then Click on File, click Protect Document, in the drop-down menu click Restrict Editing. In the column to the right at the bottom click unprotect. 5) Click on the appropriate checkboxes. 6) Save your updated version on your drive 7) Send an to DCRI Corporate Communications with your COI attached for posting on our DCRI website. Editing the Document (Necessary only when you have to add companies not on the form): 1) Scroll down to the last page to the blank rows and enter the company name(s) on the company field(s). 2) Enter new information. 3) Click on the appropriate checkboxes on your new listing and save. 4) Make sure you save your version on your drive. Column Explanations: (1) Funding is provided for my effort in research grants or contracts for multi-center projects in which I serve as either the Chairman, Co-Chairman, Executive or Steering Committee member or I am involved as a DCRI faculty leader for specific aspects in a project. A check in this column denotes that I am involved in such a research contract. Payments for the work performed for these contracts are made to the. A portion of my salary as a faculty member, representative of % effort on the project, is supported by these funds. research grant company supports the expenses associated with projects in the DUHS that are under my direction. (3) I provide educational activities or deliver occasional lectures that generate revenue company. All revenues from these activities are paid to the. None of it is taken for personal income. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (4) I receive personal income outside of my salary for consulting or other services (Including CME) company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (5) I receive personal income outside of my salary for consulting or other non-cme services company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. personally receive royalties in excess of $5,000 per year company. (7) I, or an immediate member of my family, have equity (with shareholder voting privileges) in this company of either > $5,000 or > 1%. page 1 of 10; 10/01/2012
2 DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Name: Dr. Ann Marie Navar Title: Assistant Professor of Medicine Address: 2400 Pratt St., NP.8011 Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. Lectures for CME) for >$5K/1% Abbott Laboratories AbbVie Abiomed Achillion Acorda Therapeutics, Inc AGA Medical Alcon Altarum Amerigroup Corp. Amgen, Amylin, Anadys Angel Medical Systems, 2 of 10;10/01/2010
3 Lectures for CME) for >$5K/1% Aptus Endosystems, ARCA Biopharma Ardea Biosciences, Astellas Pharma US AstraZeneca Atritech Baxter Bayer US (Bayer AG/Bayer in Japan subsidiaries) Bayer HealthCare (formerly Berlex Labs) Bellerophon Therapeutics BioCryst Biomarin Biomarker Factory Biscardia, Boehringer Ingelheim Boston Scientific Bristol Myers Squibb 3 of 10;10/01/2010
4 Lectures for CME) for >$5K/1% CardioDx, Cardiovascular Systems, Cardioxyl Cempra, Cerexa, Charles River Laboratories Cochrane Collaboration Critical Diagnostics CSL Limited Cubist Daiichi Sankyo Co. Limited Dr. Reddy s Laboratories LTD Drip Drop Durata Therapeutics Edwards Lifesciences Elesvier Eli Lilly & EOCI Pharmacomm Ltd. 4 of 10;10/01/2010
5 Lectures for CME) for >$5K/1% Evalve, Exelixis, F2G, Ltd. Ferring Genentech General Electric Healthcare Genzyme Gilead Sciences, Glaxo SmithKline (GSK) HeartFlow Helsinn Healthcare Hologic, Idera Pharmaceutical, INC Inimex International Stem Cell Iris Molecular Diagnostics Janssen Pharmaceutica Products 5 of 10;10/01/2010
6 Lectures for CME) for >$5K/1% Janssen and Development, LLC Johnson & Johnson Johnson & Johnson Pharmaceutical & Development KAI Kaiser Permanente Life Masters Supported Self Care, Lilly Luitpold, MAQUET Cardiovascular LLC (formerly Boston Scientific Cardiac & Vascular) Medafor, Medtronic Vascular, (formerly Medtronic AVE) Medtronic, Merck & Co. Merck Group Merck Laboratories 6 of 10;10/01/2010
7 Lectures for CME) for >$5K/1% Merck Sharp & Dohme I.A. Miracor Medical Systems Molecular Insight Murdock Mylan Laboratories, Novartis Pharmaceutical Ophthotech OrbusNeich Orexigen Therapeutics, Ortho-McNeil- Janssen, OSI Eyetech Otsuka America Pharmaceutical Oxygen Biotherapeutics PENTAX Medical 7 of 10;10/01/2010
8 Lectures for CME) for >$5K/1% Perosphere, Pfizer Pharmacyclics Pharmos Portola Pharmaceutical Progenics Protalix Purdue Pharma Reata Regado Biosciences, Regeneron, Revalesio Corp Roche Diagnostic Corp. Roche Group Roche Molecular Systems, RTI Health Solutions Sage Therapeutics Sanofi-Aventis Santaris Pharma A/S 8 of 10;10/01/2010
9 Lectures for CME) for >$5K/1% Schering-Plough Scios, Seaside Therapeutics Somahlution, Svelte Medical Sytems, Tacere Therapeutics Takeda Pharmaceutical Co. Tethys Bioscience TEVA industries The Medicines Thoratec Versartis, Vertex, Volcano Westat 9 of 10;10/01/2010
10 Lectures for CME) for >$5K/1% Column Explanations: (1) Funding is provided for my effort in research grants or contracts for multi-center projects in which I serve as either the Chairman, Co-Chairman, Executive or Steering Committee member or I am involved as a DCRI faculty leader for specific aspects in a project. A check in this column denotes that I am involved in such a research contract. Payments for the work performed for these contracts are made to the. A portion of my salary as a faculty member, representative of % effort on the project, is supported by these funds. research grant company supports the expenses associated with projects in the DUHS that are under my direction. (3) I provide educational activities or deliver occasional lectures that generate revenue company. All revenues from these activities are paid to the. None of it is taken for personal income. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (4) I receive personal income outside of my salary for consulting or other services (Including CME) company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (5) I receive personal income outside of my salary for consulting or other non-cme services company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. personally receive royalties in excess of $5,000 per year company. (7) I, or an immediate member of my family, have equity (with shareholder voting privileges) in this company of either > $5,000 or > 1%. 10 of 10;10/01/2010
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
More information(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationMethod of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
More informationOwnership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More informationTRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
More informationEarly Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationEuropean companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
More informationMonetizing Early-Stage R&D Assets. March 18, 2015
Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
More informationHEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging
Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationThe 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
More informationAppendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics
Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Conference Co-Chairs Dr. Richard Popp Acumen Medical Pelikan Technologies Percardia, Inc. Acumen Medical Agilent
More information2017 IPCC Attendee List
2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.
More informationACC.17 Program Committee Disclosures of Relationships With Industry Disclosures
ACC.17 Program Committee of Relationships With Industry Name Brian G. Abbott, MD, J. Dawn Abbott, MD, DATA SAFETY MONITORING BOARD - Pfizer Nazem Akoum, MD, CONSULTANT FEES/HONORARIA - Biotronik Karen
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationCommittee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
More informationHESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09
HESI Annual Meeting January 19, 2009 Welcome!!!! Meeting of the HESI Assembly of Members Dr. James MacDonald President of HESI The HESI logo... Depicts our commitment to the tripartite approach... Government!
More informationDISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Controversies and Advances in the Treatment of Cardiovascular Disease The Sixteenth in the Series November 17 & 18, 2016 Montage Beverly Hills DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS In accordance
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationSZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
More informationLIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationThe 2010 EU industrial R&D investment SCOREBOARD
1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D
More informationHeart Valve Summit: Medical, Surgical and Interventional Decision Making
Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More information2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions FRIDAY, 4 MAY 8:30 AM 3 PM New York Genome Center 101 Avenue of the Americas New York, NY 10013 HBAnet.org Event
More informationACC.13 Committee Disclosures Page 1 of 9
ACC.13 Program Committee Disclosures Last First Direcr Grants Alexander Karen P. Gilead Sanofi Aventis Ananthasu Karthikeya Lantheus Imaging bramaniam n Lantheus Imaging, Astellas Pharma US, Inc Astellas
More informationCardiac Safety Research Consortium: A Decade of CSRC. Mitchell W. Krucoff, MD, FACC
Cardiac Safety Research Consortium: A Decade of CSRC Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC
More informationThis report is prepared by:
Access to Medicine Index 2010 Access to Medicine Foundation The Access to Medicine Foundation is an international not for profit organization dedicated to improving access to medicines to societies in
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationCommittee Disclosures Page 1 of 12
TCT@ACC-i2 Program Committee Disclosures Last Name First Name Middle Name Nothing to Grants Abbott J. Dawn X Abizaid Alexandre Abbott, Boston Scientific Angiolillo Dominick J. Eli Lilly, Daiichi-Sankyo,
More informationMixed Signals: Understanding the Outlook for Pharma R&D Spending Through
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,
More information2018 IPCC Attendee List
2018 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2018 Title Head of Intellectual Property Vice President IP Asst. Program Officer Health Supervisor Public Health Asst. Health Youth
More informationResearched Medicines Industry Association of New Zealand Incorporated
MResearched Medicines Industry Researched Medicines Industry Association of New Zealand Incorporated Submission on Patents Bill to the Commerce Select Committee July 2009 Researched Medicines Industry
More information1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner
Photo Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof, MD Family Name(s): Pürerfellner First Name(s): Helmut Friedrich Birth Date: 02-Apr-1961 Type of address:
More informationACC.18 ABSTRACT REVIEWERS Disclosures
Name A. Michael Lincoff, M.D., FACC RESEARCH/RESEARCH GRANTS - AbbVie, Inc., Amgen, Astra Zeneca, Cerenis, CSL Behring, Edwards Lifesciences, Esperion, Ethicon, Infraredx, Janssen, Johnson & Johnson, Lilly,
More informationHealthcare and Life Sciences Group. Mergers & Acquisitions
Healthcare and Life Sciences Group Mergers & Acquisitions Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationOfficer Director etc. Ownership Partnership Principal. Speaker's Bureau
ACC.14 and TCT@ACC-i2 Program Committees' Disclosures of Relationships with Industry Moniring Last Abbott J. Dawn YES YES Pfizer Bosn scientific Adams David H. YES YES Medtronic, Edwards Lifesciences,
More informationIP for Development Indian Approach
ARAB REPUBLIC OF EGYPT MINISTRY OF FOREIGN AFFAIRS ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY WORLD INTELLECTUAL PROPERTY ORGANISATION Second WIPO Inter-Regional Meeting on South-South Cooperation on
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationPeter Forman President & CEO South Shore Chamber of Commerce
June 28, 2018 Peter Forman President & CEO South Shore Chamber of Commerce George Toma Chairman South Shore Chamber of Commerce Jim McDonough President & CEO Envision Bank Elliot F. Eisenberg, Ph.D. President:
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationSay on Pay at the Life Sciences 80 A Final Look at 2015 Before we turn our full attention to the
January 11, 2016 compensia.com Say on Pay at the Life Sciences 80 A Final Look at Before we turn our full attention to the upcoming 2016 proxy season, it s time to take a final look at the results for
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationCAN Company Name M Company A A A A O N Corporation A T & T Corp Abbvie Corp Accenture Ltd.
CAN Company Name 005004 3 M Company 005010 A A A 007372 A O N Corporation 005207 A T & T Corp 020609 Abbvie Corp. 017610 Accenture Ltd. 008785 Adidas Corp 017083 Advanced Micro Devices 020742 Aflac - Corp.
More informationSpeakers' Portal WIP18 CME Disclosure Form Results
' Portal WIP18 CME Disclosure Form Results Last Name First Name Roles Relationships Company Name Aasvang Eske Agur Anne Allegri Massimo Argoff Charles Poster/Oral Presenter Assis Fabricio Basbaum Allan
More informationSPC developments in Europe AIPPI Marjan Noor Simmons & Simmons
SPC developments in Europe AIPPI 2012 Marjan Noor Simmons & Simmons Requirements for obtaining an SPC (Reg 469/2009) The product is protected by a patent (Art 3(a)) There is a marketing authorisation (MA)
More informationVALUE IN HEALTH 20 (2017) A384 A397
A384 VALUE IN HEALTH 20 (2017) A384 A397 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract
More informationMARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013
MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters
More information30th Annual Oncology Nurses Symposium
E X H I B I T O R P R O S P E C T U S 30th Annual Oncology Nurses Symposium S E P T E M B E R 2 6-2 9, 2 0 1 0 H I L T O N S A N D I E G O R E S O R T Scripps Conference Services & CME www.scripps.org/conferenceservices
More informationIPCAA. Regulatory awareness still needs improving. INTERNATIONAL PHARMACEUTICAL CONGRESS ADVISORY ASSOCIATION No. 35 July 2010
IPCAA NEWS Regulatory awareness still needs improving Following continuing efforts to promote awareness of pharmaceutical industry codes and regulatory constraints on sponsors for medical congresses, it
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationThe importance of transnational corporations in research and development activities in the world
Jagiellonian Journal of Management vol. 3 (2017), no. 2, pp. 65 75 doi:10.4467/2450114xjjm.17.005.7735 www.ejournals.eu/jjm The importance of transnational corporations in research and development activities
More informationVALUE IN HEALTH 18 (2015) A308-A318
A308 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose fi nancial
More informationDisclosures of Relevant Financial Relationships
Disclosures of Relevant Financial Relationships Disclosure Policy It is the policy of the Society of Cardiovascular Anesthesiologists (SCA) that the planners, faculty, and reviewers disclose the existence
More informationInstitutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant
Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,,
More informationSkystar Bio-Pharmaceutical Co SKBI
Morningstar Analyst Rating Page 1 of 6 Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 0.00 [0.00 0.00 % $ 0.00 0.00-0.00 0.00-0.10
More informationSkystar Bio-Pharmaceutical Co SKBI
Morningstar Analyst Rating Page 1 of 6 Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 0.01 [0.00 0.00 % $ 0.01 0.01-0.01 0.00-0.20
More informationOffice of Inspector General Update
Office of Inspector General Update 15th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum November 3, 2014 Mary E. Riordan, Senior Counsel Office of Counsel to the Inspector
More information9455 TOWNE CENTRE DRIVE CLASS-A LIFE SCIENCE + OFFICE
9455 TOWNE CENTRE DRIVE CLASS-A LIFE SCIENCE + OFFICE 1 INTRODUCING A FRESH, UNIQUE PERSPECTIVE Located in the prestigious and amenity-rich University Towne Centre, 9455 Towne Centre Drive is the next
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationForm FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.
Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be
More informationJohnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile
Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research
More informationMATCHING GIFT COMPANY LIST
MATCHING GIFT COMPANY LIST This is a list of corporations that have matched donations to events benefiting Susan G. Komen for the Cure in the past. Please review your corporation s matching gift guidelines
More informationLife Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. New Jersey JLL Research
Life Sciences New Jersey 2017 An evolving industry: Today s clusters creating tomorrow s breakthroughs JLL Research 2 New Jersey Over the course of the past 130 years, the pharmaceutical/life sciences
More informationGilead Sciences. Very interesting in all areas. COMPANY Gilead Sciences Inc. INDUSTRY Biotechnology TYPE Public Company TICKER NasdaqGS:GILD
Simply Wall St provides a completely new visual way to invest in the stock market. To see other infographic reports like this one for Apple check out simplywall.st. Very interesting in all areas. COMPANY
More informationEuropean Patent Reform Forum USA December , New York
European Patent Reform Forum USA December 8 2015, New York Delegate List Job Title Organisation SVP/ Senior IP Law ACell ADP Law Vice President Director Senior Manager, Licensing, IP Law Global, Diabetes
More informationPublication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter
Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter Pharma Boardroom An Exclusive Interview with Jonathan Hunt CEO, Syngene International, India. Jonathan Hunt, CEO of Syngene International,
More informationPeople. Move PHARMA COMPANIES. on the. Abbott Nutrition International. AstraZeneca. Axcan Pharma. Berlex. Bristol-Myers Squibb
People on the Move PHARMA COMPANIES Gary Schmid Abbott Nutrition International Crawford Wright AstraZeneca Abbott Nutrition International Gary Schmid, formerly Director of Marketing, Primary Care Division,
More informationVanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited
More informationWilliam E. Solander. Case Highlight
...an insightful patent litigator with sound judgment who is capable of achieving effective results when solving legal and business issues. (Best Lawyers 2014) Contact William E. Solander Partner wsolander@fchs.com
More informationInternational Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs
International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs Do you want to strengthen your business plan for your company?, or refresh your
More information2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA
Learner Notification 2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity.
More informationNOTICE OF ANNUAL GENERAL MEETING. Thursday 30 March 2017 at am. H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Thursday 30 March 2017 at 10.00 am The general
More informationMedAdNews. themagazineofpharmaceuticalbusinessandmarketing medadnews.com october2007. What leaders need
MedAdNews themagazineofpharmaceuticalbusinessandmarketing medadnews.com october2007 What leaders need Leaders from across the pharmaceutical and biotechnology industry discuss the experiences and characteristics
More information7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August Exhibitor Prospectus. About the Course
7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August 2010 Exhibitor Prospectus About the Course During Scripps Clinic s Oncology Update course, clinical experts will review
More informationLast Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF
Page 1 of 6 Morningstar Analyst Rating. Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 86.57 ]1.05 1.23 % $ 86.09 85.93-86.75
More informationAre European firms falling behind in the global corporate research race?
Policy Contribution Issue n 06 April 2018 Are European firms falling behind in the global corporate research race? Reinhilde Veugelers Executive summary Reinhilde Veugelers (reinhilde.veugelers@ bruegel.org)
More informationWomen leaders transforming the future through gender partnership
On behalf of the 3BC steering committee, HBA senior advisory board and board of directors, we wish to warmly invite you to: Building Better Business Connections (3BC) annual executive summit Women leaders
More information2018 AATS/ACC/SCAI/STS
Reviewer Relationships With Industry and Other Entities (Comprehensive) 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Requirements for Transcatheter Aortic
More informationTODAY LETTER DATED
TODAY LETTER DATED 05.07.2018 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD-380054 23483 CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE-
More informationHall of Fame. Inducting the 2011 Class Into the DTC Hall of Fame
Inducting the 2011 Class Into the DTC DTC Perspectives proudly welcomed four outstanding executives into the DTC Hall of Fame for their significant achievements in advancing DTC communications. The 2011
More informationPerspectives on Sustainable Growth
Perspectives on Sustainable Growth Series Editor Min Ding Smeal College of Business The Pennsylvania State University University Park, PA, USA and School of Management Fudan University Shanghai, China
More informationGenerics Series: Authorized Generics Analysis Stemming the Generics Tide
Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players
More informationAbbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO
Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO FORWARD LOOKING STATEMENT Some statements in this presentation may be forward-looking
More information